| Abstrakt: |
A recent study conducted by the Arthur Riggs Diabetes and Metabolism Research Institute in Duarte, California, has focused on the role of G-protein coupled receptor 44 (GPR44) in inflammation-related diseases such as cancer and diabetes. The researchers aimed to develop GPR44 radiotracers to better understand the mechanism of GPR44 and monitor therapy progress. They successfully synthesized a radiotracer called [18F]TM-30089, which showed promising results in targeting GPR44 in mice models. Further evaluation of this radiotracer is currently underway. This research provides valuable insights into the potential use of [18F]TM-30089 in the treatment of inflammation-related diseases. [Extracted from the article] |
